Bone Mineral Density
Physical exercise may minimize bariatric surgery-induced bone loss
A supervised, multicomponent physical training program was associated with bone mass benefits for adults who had bariatric surgery, according to findings published in the Journal of Bone and Mineral Research.
Bone mineral density testing rates still low among men receiving ADT for prostate cancer
Rates of bone mineral density testing among men with prostate cancer undergoing androgen deprivation therapy have risen since 2000 but remain low, according to study results published in Journal of the National Comprehensive Cancer Network.
Denosumab superior to alendronate in raising spinal BMD in long-term glucocorticoid users
Among patients using long-term glucocorticoids, denosumab is superior to alendronate in increasing bone mineral density in the spine after 1 year, according to a speaker at ACR Convergence 2020.
Romosozumab linked to 'substantial gains' in hip, lumbar spine bone mineral density
Romosozumab as a first treatment produces ‘substantial gains’ in hip and lumbar spine bone mineral density within 1 year, a result that is augmented by then transitioning to a potent antiresorptive, according to a study.
Good bone quality linked to better CV health for UK adults
Participants in the UK Biobank who had a higher bone speed of sound were more likely to have good cardiovascular health, according to a study published in The Journal of Bone and Mineral Research.
Low BMD, fracture risk unrelated to genetic risk for hyperthyroidism
Increased genetic risk for Graves’ disease, autoimmune thyroiditis or hyperthyroidism is not associated with low bone mineral density or fracture risk, according to an analysis of UK Biobank data.
Preoperative bone health screening should be considered for patients older than 50 years
Due to a high prevalence of osteoporosis and degraded bone health in patients older than 50 years, surgeons should consider fracture risk assessment and dual X-ray absorptiometry prior to surgery, according to an orthopedic specialist.
Despite 'great strides' in osteoporosis, questions remain
Novel therapies are providing hope in osteoporosis, but questions surrounding optimal treatment regimens remain, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.
Treatment sequence influences romosozumab effectiveness in osteoporosis
Women with osteoporosis who received romosozumab experienced the greatest gains in bone formation when the drug was administered before antiresorptive therapy, according to a speaker.
Osteoporosis therapies reduce fracture risk for women regardless of BMD status
Osteoporosis therapies work equally well for women at high risk for fracture with high or low bone mineral density, according to data from the virtual American Society for Bone and Mineral Research Annual Meeting.